(Q36024876)

11 August 2017

Population pharmacokinetics of darbepoetin alfa in healthy subjects (English)

1 reference

11 August 2017

0 references

1 reference

Balaji Agoram

1

1 reference

11 August 2017

Liviawati Sutjandra

series ordinal

2

1 reference

11 August 2017

John T Sullivan

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

30 August 2006

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

63

1 reference

11 August 2017

1

1 reference

11 August 2017

41-52

1 reference

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Novel erythropoiesis stimulating protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Lymphatic transport of proteins after subcutaneous administration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Stability and performance of a population pharmacokinetic model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000706

Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency.

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02752.X

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02752.X

A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02752.X

Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02752.X

Assessment of actual significance levels for covariate effects in NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02752.X

Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02752.X

Pharmacokinetics and leukocyte responses of recombinant human interleukin-10

21 January 2018

1 reference

12 December 2020

Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease

1 reference

12 December 2020

Once-Monthly Administration of Darbepoetin Alfa for the Treatment of Patients with Chronic Heart Failure and Anemia

1 reference

12 December 2020

Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients

1 reference

12 December 2020

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

1 reference

12 December 2020

Commentary on significance levels for covariate effects in NONMEM

1 reference

12 December 2020

Age and the incidence of sentinel lymph node metastases in melanoma

1 reference

12 December 2020

Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model

1 reference

12 December 2020

Diurnal variations of serum erythropoietin in trained and untrained subjects

1 reference

12 December 2020

Lymphatic absorption of retinol in young, mature, and old rats: influence of dietary restriction

1 reference

12 December 2020

Population pharmacokinetics of erythropoietin in critically ill subjects

1 reference

12 December 2020

10.1111/J.1365-2125.2006.02752.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

16939525

1 reference